Cara Therapeutics | CARA - Market Capitalization


Cara Therapeutics reported $61.1M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Cara Therapeutics USD 30M 336M Mar/2026
Cassava Sciences USD 82M 14M Mar/2026
Chugai Pharma JPY 12.65T 1.81T Jun/2026
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Pacira USD 998M 83M Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
RedHill Biopharma USD 1000K 4M Sep/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024